Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 1 February 2007, Vol. 109, No. 3, pp. 855-856.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hoag, K. A.
Right arrow Articles by Lackey, D. E.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Hoag, K. A.
Right arrow Articles by Lackey, D. E.
Related Collections
Right arrowRelated Article in Blood Online
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

InsideBlood

HEMATOPOIESIS

Comment on Taschner et al, page 971

RXR: no longer a stepchild

Kathleen A. Hoag, and Denise E. Lackey

MICHIGAN STATE UNIVERSITY

The nuclear receptor superfamily contains members with known ligands, orphans, and RXR playing a subservient role as heterodimer partner. Taschner and colleagues demonstrate that RXR{alpha} may be more than a stepchild.

RAR{alpha} and its heterodimer partner retinoid X receptor (RXR) are members of the nuclear receptor superfamily.1 Nuclear receptor superfamily members have been documented to form heterodimers with RXR. These heterodimers act as transcription factors, binding to DNA response elements usually located in the 5' untranslated regions of genes. Presence or absence of the ligand for the RXR heterodimer partner controls recruitment of coactivator or corepressor proteins to regulate gene transcription. However, 2 fundamental questions remain largely unresolved: (1) does RXR and its ligand 9-cis retinoic acid (9cRA) contribute to transcriptional regulation mediated by RXR heterodimers; and (2) do RXR/RXR homodimers play important roles in regulating gene transcription independently of RXR heterodimers?

In this issue of Blood, Taschner and colleagues present strong evidence that RXR{alpha} plays an instrumental role in controlling myeloid developmental cell fate. In a series of elegant experiments, the investigators demonstrated that down-regulation of RXR{alpha} protein is required for neutrophil development, while maintenance of RXR{alpha} supports development of monocytes. Taschner and colleagues first demonstrated this using primary CD34+ progenitor cell cultures containing a mixture of growth factors plus granulocyte colony-stimulating factor (G-CSF) or macrophage colony-stimulating factor (M-CSF) to drive neutrophil or monocyte development, respectively. They further verified that neutrophils and monocytes isolated from peripheral blood also showed this pattern of RXR{alpha} protein expression.

Next, Taschner and colleagues used expression vectors containing either functional full-length or truncated dominant-negative RXR{alpha}{Delta} in combination with RXR{alpha} agonist to determine whether the RXR{alpha} protein itself could alter myeloid development. In addition, they also tested the effects of either vitamin A (as RAR ligand all-trans retinoic acid [ATRA] or 9cRA) or vitamin D (as 1,25-dihydroxyvitamin-D3 [VD3]) in the presence and absence of these expression vectors, since vitamin A is known to promote neutrophil development, while vitamin D promotes monocyte development. Addition of RXR{alpha} agonist to cells transfected with either an empty vector or full-length RXR{alpha} switched cell fate choice from neutrophils to monocytes despite culture in neutrophil-promoting medium containing G-CSF. Further, addition of VD3, but not ATRA or 9cRA, promoted monocyte development in cultures containing G-CSF, and this effect was significantly inhibited by dominant-negative RXR{alpha}. In all cases tested, dominant-negative RXR{alpha} inhibited monocyte development and promoted neutrophil development. Further data presented by the authors suggest that RXR{alpha} inhibits neutrophil development at least partially by interfering with neutrophil proliferation.

Although Taschner and colleagues provide convincing evidence of a prominent role for RXR{alpha} in the later stages of myeloid development, their studies do not provide convincing evidence as to whether RXR{alpha} is functioning as a homodimer or heterodimer in this system. Recently, Vivat-Hannah and colleagues2 have described specific mutations of RXR that strongly influence the ability of this receptor to form heterodimers versus homodimers. Future studies using these mutated RXR constructs may be able to provide insight into this as yet unresolved question.

Footnotes

The author declares no conflicting financial interests. {blacksquare}

References

  1. Evans RM. The nuclear receptor superfamily: a rosetta stone for physiology. Mol Endocrinol 2005; 19:1429–1438.[Free Full Text]

  2. Vivat-Hannah V, Bourguet W, Gottardis M, Gronemeyer H. Separation of retinoid X receptor homo- and heterodimerization functions. Mol Cell Biol 2003; 21:7678–7688.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article in Blood Online:

Down-regulation of RXR{alpha} expression is essential for neutrophil development from granulocyte/monocyte progenitors
Sabine Taschner, Christina Koesters, Barbara Platzer, Almut Jörgl, Wilfried Ellmeier, Thomas Benesch, and Herbert Strobl
Blood 2007 109: 971-979. [Abstract] [Full Text] [PDF]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hoag, K. A.
Right arrow Articles by Lackey, D. E.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Hoag, K. A.
Right arrow Articles by Lackey, D. E.
Related Collections
Right arrowRelated Article in Blood Online
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2007 by American Society of Hematology         Online ISSN: 1528-0020